DONATE NOW
Menu
Menu graphic element
CONTACT US
Experiment
Line separator

LATEST
NEWS

Search
The FDA rejects celiprolol - how should we interpret the news?
Dave DeMasi
  • Jun 28, 2019
  • 3 min

The FDA rejects celiprolol - how should we interpret the news?

103 views0 comments
NEW STUDY: vEDS patients are living longer, but unclear what role celiprolol plays
John DeMasi
  • May 15, 2019
  • 3 min

NEW STUDY: vEDS patients are living longer, but unclear what role celiprolol plays

121 views0 comments
Longer Life with vEDS: A Lesson from Marfan Syndrome
John DeMasi
  • Nov 28, 2018
  • 5 min

Longer Life with vEDS: A Lesson from Marfan Syndrome

241 views0 comments
The 4 Essential Elements of your vEDS Care Team
John DeMasi
  • Sep 6, 2018
  • 4 min

The 4 Essential Elements of your vEDS Care Team

14 views0 comments
The University of Washington and FIGHT vEDS ask patients to set the research agenda
Dave DeMasi
  • Jan 31, 2018
  • 2 min

The University of Washington and FIGHT vEDS ask patients to set the research agenda

0 views0 comments
Congress Attempts to Alter the Orphan Drug Tax Credit
Dave DeMasi
  • Nov 13, 2017
  • 3 min

Congress Attempts to Alter the Orphan Drug Tax Credit

3 views0 comments
5 Tips from Benjamin Franklin for vascular EDS
John DeMasi
  • Aug 28, 2017
  • 4 min

5 Tips from Benjamin Franklin for vascular EDS

5 views0 comments
Acer Therapeutics Obtains Exclusive License to Celiprolol Study Data
John DeMasi
  • Dec 14, 2016
  • 1 min

Acer Therapeutics Obtains Exclusive License to Celiprolol Study Data

4 views0 comments

DONATE 

TO FIGHT vEDS

Donate Now

SUBSCRIBE TO OUR UPDATES

Thanks for submitting!

Contact Us

Thanks for submitting!

Privacy Statement          Legal Terms and Conditions

©2021 By Green Ivy Health Inc.

Back to Top